abstract |
The present invention relates to compounds of the formula (I) (see formula (I)) that have activity as S1P receptor modulating agents, more specifically to specific compounds that are S1P1 receptor agonists. The invention also relates to the use of these compounds to treat diseases associated with inappropriate activity of the S1P1 receptor, such as autoimmune diseases. |